Showing 34,667 results

Treatment for women

Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

Editor's pick
The BodyPro
1 March 2011
Starting treatment

3-year results on Merck’s ISENTRESS® (raltegravir): sustained viral load suppression and tolerability

Editor's pick
Business Week
1 March 2011
Finance & funding

Winners and losers in the UK aid review

Editor's pick
The Guardian
1 March 2011
HIV treatment

Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against Abbott

Editor's pick
Bloomberg
1 March 2011
Viral load

Treatment monitoring: no clear benefit to adding viral load to CD4 or clinical symptoms in Thailand and Africa

News
1 March 2011
Finance & funding

UK aid budget refocuses 'on areas of greatest need'

Editor's pick
The Guardian
1 March 2011
New & experimental HIV treatments

Attachment inhibitor BMS-663068 potent and well-tolerated in early study

News
1 March 2011

Choose your runner

News
1 March 2011
New & experimental HIV treatments

Towards a cure for all: How we might do it

News
1 March 2011
Sexual transmission

Safer sex in the treatment era

News
1 March 2011
The search for an HIV prevention vaccine

What about a vaccine?

News
1 March 2011
Ethnic & cultural minorities

Risk of Virologic Failure 40 Percent Higher Among Blacks vs. Whites

Editor's pick
Kaiser Daily Global Health Policy Report
1 March 2011
Treatment outcomes & life expectancy

Risk of Virologic Failure 40 Percent Higher Among Blacks vs. Whites

Editor's pick
AIDSMeds
1 March 2011
New & experimental HIV treatments

Zinc finger gene therapy produces HIV-resistant CD4 T-cells

News
1 March 2011
Vaginal rings & topical PrEP

Vaginal microbicides may not be safe for rectal use: gels being reformulated

News
1 March 2011
Vaginal rings & topical PrEP

One dose of raltegravir gel three hours after sex might prevent HIV infection

News
1 March 2011

Eviplera

About HIV
March 2011
TB treatment

Antiretroviral treatment in TB patients: patients with CD4 counts below 50 need to start ART quickly

News
28 February 2011
PrEP science

Truvada PrEP remains effective against HIV with 3TC/FTC resistance in animal study

News
28 February 2011
Self-testing & home testing

Self-testing for HIV proves highly acceptable in Malawi

News
28 February 2011
Circumcision

Five years on from circumcision trial, nine in ten participants are circumcised and HIV incidence is two-thirds lower

News
28 February 2011
Pregnancy and vertical transmission

Uganda: Cash Crunch Delays Shift to WHO-Recommended PMTCT Regimen

Editor's pick
IRIN Plus News
28 February 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
Bloomberg
28 February 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
28 February 2011